Abstract -In our efforts aimed at the discovery of new natural products of biological and, eventually, therapeutic interest, we have become particularly interested in the following three areas: (i) Anticancer chemotherapy: the derivatives of vinbiastine 1 and those of ellipticine 13 have been especially studied; (ii) The central nervous system, wherein we have looked for new substances which can interact with the benzodiazepine receptor.
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Derivatives of Vinblastine
The discovery, in our laboratory, of a new, "biomimetic" synthesis of the dimeric indole alkaloids of the vinblastine group (ref. 1 ,2) has permitted access to original derivatives heretofore unobtainable by simple chemical modification of the natural extraction products. Several of these new derivatives have shown potent antitumor activity and one of these, navelbine 12, which is currently undergoing phase II clinical trials, raises serious hopes of eventuaTtherapeutic applications. Catharanthine N-oxide 8, easily obtained from catharanthine 6, treated with trifluoroacetic anhydride, undergoes fragmentation reaction, leading to Thn iminium intermediate 9
attack of this intermediate 9 by the vindoline 7, acting as a large nucleophile, leadc to the 16'S derivative ("natural" series) whose rduction in situ with sodium borohydride provides anhydrovinblastine 10 (Scheme 1). This latter derivative can be transformed into various dimeric alkaloids dibvered in some species of Catharanthus, in particular C. roseus, and thus constitutes a key intermediate in the biosynthesis of these compi natural products (ref.
3). Navelbine has demonstrated an ability to inhibit in vitro the polymerisation of tubut in, superior or equal to that of vinblastine or vincristine, respectively (ref. 4 ). This compound is actually undergoing phase II clinical trials and already appears to be an antitumor agent likely to reinforce our therapeutic arsenal.
The essential structural difference between navelbine 12 and the vinblastine derivatives 1 or 2 resides in the contraction of ring C of this moletiie (9-membered ring + 8-membered rin) and, especially, of the presence on this ring of a gramine-type partial structure. Now, the little we know of the relations between structure and biological activity of the compounds of the vinblastine series indicates that the pK of the Nb nitrogen atom is very important this nitrogen atom must be capable of being protonated.
Unfortunately, we know very little about the precise nature of the interactions of vinblastine-type molecules with tubulin. This; of course, is partly due to the fact that the exact structure of tubulin is not presently known and it is thus impossible to fully appreciate the nature of the interactions between these "spindle poisons" and their fixation sites on this protein. The preparation of radioactive derivatives of navelbine should allow us to verify the validity of these hypotheses.
It should be added that the C-nor-vinblastine-type structure present in navelbine has not yet been found in nature while anhydrovinblastine 10, from which it is derived, was first The derivatives of an isomer of ellipticine, olivacine 16, are also active antitumor agents but have not to this day reached the level of deve(ment of certain of the ellipticine derivatives.
The mechanism of action in vivo of these pyridocarbazole derivatives is not well known even though many in vitro experiments have permitted these compounds to be classed as DNA intercalating agents.
The discovery of the alkylating properties of sile oxidized derivatives of ellipticine by
Paoletti, Meunier and coIl. constitutes an important step in understanding the mechanism of action of these compounds (ref. 10). In effect, these authors showed that compounds as structurally varied as amino acids, glutathione and nucleosides could add to position 10 of the iminoquinone species, the latter obtained by oxidation of hydroxyellipticine-type derivatives (Scheme 4). However, the structures proposed for these adducts formed between hydroxyellipticine and nucleophiles have been modified as a result of our own work (ref. 11, 12) .
The high affinity of ellipticine and its derivatives for DNA-type structures (10 to 10 M) and the intercalation of these types of molecules within the DNA structure were long considered the two most important factors in explaining their biological and therapeutic activities.
In fact, derivatives of ellipticine are known (9-amino or 9-fluoro) which bind to DNA with as high an affinity as 9-hydroxyellipticine but which demonstrate little or no antitumor activity. This observation led to the proposal that DNA may not be the only biological target of ellipticine-type derivatives.
In effect, 9-hydroxyellipticine or its quaternary ammonium derivative 17 can be easily oxidized to give iminoquinone derivatives such as 18 (ref. 10) . These iminoquinone species are excellent electrophiles to which extremely varied nucleophiles (amino acids, thiol derivatives, alcohols, amines, nucleosides, etc.) can add to position 10 (Scheme 4) (ref. 7, 8, 10, 11, 12) .
Among the excellent biological nucleophiles which can add to position 10 of the iminoquinone species formed by oxidation are, in fact, the ribonucleosides. Thus, 9-hydroxyellipticine is easily oxidized (for example, by hydrogen peroxide and by Horse-radish peroxidase) to the iminoquinone 18 which typically can undergo a first nucleophilic addition (N ), leading to a primarydduct 19 (not always isolable in view of its instability). This adduct gives rise to a phenolic deriVative by proton shift which, in turn, is again oxidized, leading to a new iminoquinone structure capable of undergoing a second nucleophilic addition (e.g. 21 or 22). The case of glycol addition 22 is particularly interesting since such a cis 1,2-glycol group is found in the ribose unit of ribonucleosides and nucleotides which compose RNA.
Obviously, it can easily be seen why the many studies concerning the interaction between small molecules and nucleotide substrates have dealt mainly with DNA, whose preparation is relatively simple, beginning, for example, with calf thymus. The preparation of RNA of purity comparable to that of DNA is much more difficult.
If a compound such as 17 is oxidized (for example, with hydrogen peroxide and Horse-radish peroxidase) id the product reacted with adenine (A), guanine (G), cytosine (C) or uracil (U), we note that the reactivities decrease in the order A > G >> C > U. There exists a large difference in reactivity between the purine bases A and G, c°Me which react very rapidly, and the pyrimidine bases, C and T, which react much more slowly. Furthermore, A reacts better than C. Finally, a regioselectivity is observed in this reaction between 17 and each of the four bases, such that only position 10 of 17 is affected. This regioselectivity can be explained by an appropriate positioning of théiwo reactive species, the heterocycles of the purine (and pyrimidine) bases being stacked above (and below) rings C and D of the pyridocarbazole derivatives (e.g. 17). Thus, the two hydroxyl groups at positions 2' and 3' of the ribose moiety of purine (r pyrimidine) nucleosides also react solely at position 10 of the iminoquinone (e.g. 18) th give structures of type 23. If the same reaction is attempted with 2-deoxy-adenosine (DNA-type structure), no addition is observed (ref. 8). The simultaneous presence of two cis-glycol hydroxyls at positions 2' and 3' of the ribose portion is thus necessary.
As the result of these observations, we were led to propose that the antitumor activity of the pyridocarbazole class of compounds (and perhaps of other related structures such as the anthracyclinones) could result from this type of reaction on the A or poly A' terminals which are found in cellular ribonucleic structures. Thus, it is conceivable that all or part of the biological activity of these antitumor products is a result of a blocking of the nucleoide terminals which are found in t-RNAs or m-RNAs. The cellular machinery would thus be completely disorganized (ref. 13, 111 ).
The inhibition of polyribonucleotide synthesis and of the elongation of polypeptide chains by olivacine 16 (ref. 15) can also be explained by this type Of reaction and reinforces our hypothesis.
In conclusion, we can affirm that mere intercalation of ellipticine-type molecules with the DNA structure does not sufficiently account for the biologial activity of these compounds.
The formation of covalent compounds between these pyridocarbazole (or related) structures and ribonucleotide structures must not only also be taken into account but may, in fact, represent the principal mode of action in explaining the antitumour properties of these compounds. In searching for more selective antagonists of the benzodiazepines, we were led to synthesize analogues of these 3-carbolines, in particular, a series of molecules belonging to the class of 3-amino-3-carbolines 27. Although these derivatives generally had a lower affinity for the benzodiazepine rece5Thr than the parent 3-carboxy-3-carbolines, one of these compounds, 3-methoxycabonylamino-3-carboline (3-CMC, 28) had a sufficiently important affinity (IC0=4 x 10 M) and merited a closer study of its in vivo activity. We have thus been able t'o show that, at least in the mouse, 3-CMC, while displaying neither convulsant/anticonvulsant activity nor anxiolytic/anxiogenic activity, is able to effectively inhibit the sedative properties of diazepam (ref. 22 ). Consequently, 3-CMC represents the first selective antagonist of these sedative actions of benzodiazepines and may prove to be a valuable tool in studying the mechanisms of sleep and the relationship with the Scheme 5 "Peripheral" It is also a common clinical observation that the evolution of some diseases is obviously under the influence, if not the control, of the nervous system. Anxiety undoubtedly favours the development of diseases known to be highly influenced by the status of the patient's immunosystem. An "anxiety peptide" has recently been claimed to be discovered in the brain (ref. 24) .
It was therefore interesting to try to see whether some psychoactive drugs such as benzodiazepines, -carboIines or related compounds could also interfere in some way with the immune system. Indeed, we have been able to show that, among the various substances that we have examined, some belonging to the category of "peripheral-type benzodiazepines" (i.e. ligands k,own to interact with the "peripheral" benzodiazepine receptors) could stimulate, With this hypothesis, the apparent diversity of receptors could be simply the result of a sort of "mecano-type" building-up of receptors based on the aggregation of various sub-units.
With this idea in mind, we can now try to explain our results. We have shown that there are "peripheral" benzodiazepine binding sites on murine macrophages. The occupation of these binding sites by compounds like Ro 5-4864, PK 11195 or diazepam (Scheme 5) stimulates the macrophages. The exact nature of this stimulation is under current study. We have also prepared a number of -carbotine derivatives. It has been shown by Braestrup and coil. (ref. 19 ) that the ethyl ester of -carboiine-3-carboxyiic acid (ref. 24) binds very tightly to the central-type benzodiazepine receptor. Some of the compounds that we have prepared (described above) also exhibit a high affinity for the same receptors.
However, the -carboline derivatives that we have synthesized do not have a great affinity for peripheral benzodiazepine binding sites and consequently do not affect murine macrophages.
